Skin

Jurassic Park at 30: how its CGI revolutionised the film industry

Retrieved on: 
Saturday, June 10, 2023

1993’s Jurassic Park used pioneering computer-generated imagery (CGI) to bring dinosaurs to life in Steven Spielberg’s adaption of the novel of the same name.

Key Points: 
  • 1993’s Jurassic Park used pioneering computer-generated imagery (CGI) to bring dinosaurs to life in Steven Spielberg’s adaption of the novel of the same name.
  • Jurassic Park originated in 1983 as a screenplay by Michael Crichton, whose previous foray into film as writer and director of Westworld (1973) featured an immersive amusement park where androids malfunctioned and caused havoc.
  • But his dinosaur-themed story first found publication as the novel Jurassic Park, which was released in 1990 and became a bestseller.
  • Of these methods, a combination of stop-motion animation for long shots and animatronic puppets for close ups were initially chosen by Spielberg for Jurassic Park.

CGI and animation

    • Dennis Muren from the visual effects company, Industrial Light and Magic (ILM), provided an alternative approach by using CGI modelling and animation.
    • Off the back of pioneering CGI work in The Abyss (1989) and Terminator 2: Judgement Day (1991), Muren and his team produced a test sequence of skeletal dinosaurs.
    • Jurassic Park features 15 minutes of on-screen dinosaurs, of which approximately nine minutes feature Stan Winston’s animatronics and six minutes of ILM’s CGI animation.
    • Although the CGI sections are relatively short, they have a huge impact on the overall storytelling, not to mention the believability that the event is actually happening in front of us.

Impact

    • It also presented the perfect opportunity to develop and showcase the latest advances in CGI.
    • Jurassic Park inspired a number of similarly themed movies such as Disney’s Dinosaur (2000) and the award-winning BBC television series Walking with Dinosaurs (1999).
    • But more than that, it helped bring about a revolution in the use of CGI in filmmaking.

Gonorrhoea and syphilis diagnoses are at their highest in decades – here's what you need to know about these STIs

Retrieved on: 
Saturday, June 10, 2023

Shockingly, gonorrhoea rates are the highest they have been since records began in 1918.

Key Points: 
  • Shockingly, gonorrhoea rates are the highest they have been since records began in 1918.
  • Gonorrhoea has increased from 71,133 diagnoses per year before the pandemic to 82,592 in 2022.
  • Syphilis, which in the early 2000s was almost non-existent in the UK, has increased to 8,692 diagnoses in 2022.

What symptoms do they cause?

    • In women symptoms can be less obvious, but include a watery, green, yellow or sometimes bloodstained vaginal discharge, and pain when urinating.
    • Symptoms include fever and abdominal pain.
    • For this reason, it’s essential to get diagnosed and treated if you’re experiencing any symptoms.
    • The disease now enters a latent phase where it stays in the body while showing no symptoms.
    • This causes a range of symptoms which were dreaded in the years before effective treatment – including skin and bone disfigurations, nerve pain, heart problems, deafness, blindness, dementia and other neurological symptoms such as difficulty walking and incontinence.

Why have rates increased?

    • It’s not entirely clear why rates of syphilis and gonorrhoea have increased so rapidly in the UK.
    • Data shows that rates of gonorrhoea in particular are sensitive to social and political change, including changes to funding for sexual health services.

What can I do to protect myself?

    • If you have a symptom you’re worried about, get it checked.
    • Self-test kits for gonorrhoea and syphilis are available online in some areas or you can go to a sexual health clinic if you prefer.

Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023

Retrieved on: 
Friday, June 9, 2023

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, presented today updated clinical and translational data on its clinical trial BALLI-01 (evaluating UCART22) at the European Hematology Association (EHA) 2023.

Key Points: 
  • NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, presented today updated clinical and translational data on its clinical trial BALLI-01 (evaluating UCART22) at the European Hematology Association (EHA) 2023.
  • The data presented support the preliminary safety and efficacy of UCART22 in a heavily pretreated relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) population.
  • UCART22 cell expansion was detected in 9 of 13 patients in the FCA LD arm and associated with clinical activity.
  • Overall, these data support the preliminary safety and efficacy of UCART22 in this heavily pretreated r/r B-ALL population.

New Skin Tattoo Removal Expands Laser Tattoo Removal Services With the Addition of Two New Astanza Duality Lasers

Retrieved on: 
Friday, June 9, 2023

SAN JOSE, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- New Skin Tattoo Removal is proud to announce the addition of two new Duality laser machines to their tattoo removal services.

Key Points: 
  • SAN JOSE, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- New Skin Tattoo Removal is proud to announce the addition of two new Duality laser machines to their tattoo removal services.
  • With the addition of the Astanza Duality laser machines, New Skin will be able to provide laser tattoo removal to even more people at an affordable price.
  • The new location offers a wide range of services, including complete laser tattoo removal, tattoo fading, and cover-up preparation.
  • “We are thrilled to expand our services at MARS Ink Tattoo Studio,” said Adam King, owner of New Skin Tattoo Removal.

Bloomage Biotech Pioneers the Bio-Health Industry with the Launch of the World Hyaluronic Acid Valley

Retrieved on: 
Thursday, June 8, 2023

Parsippany, New Jersey, USA, June 08, 2023 (GLOBE NEWSWIRE) -- On June 3rd, Bloomage Biotech marked its presence at the distinguished Hyaluronic Acid Industry Conference in Jinan, China.

Key Points: 
  • Parsippany, New Jersey, USA, June 08, 2023 (GLOBE NEWSWIRE) -- On June 3rd, Bloomage Biotech marked its presence at the distinguished Hyaluronic Acid Industry Conference in Jinan, China.
  • The discourse aims to transcend the horizons of the hyaluronic acid industry and explore its potential as a major player in the broader bio-pharmaceutical and health sectors, initiating a dialogue about the future of high-quality development in the hyaluronic acid industry.
  • Ms. Zhao Yan, Chairperson and CEO of Bloomage Biotech, applauded the "World Hyaluronic Acid Valley" project for its substantial resource and industry strengths.
  • She envisions the future of the "World Hyaluronic Acid Valley" not merely as a hyaluronic acid industry cluster but as a trailblazer in technological innovation, industry expansion, health product consumer experience, and market application within the hyaluronic acid sector.

AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects

Retrieved on: 
Thursday, June 8, 2023

“This is a landmark approval representing an inflection point for AVITA Medical,” said Jim Corbett, AVITA Medical Chief Executive Officer.

Key Points: 
  • “This is a landmark approval representing an inflection point for AVITA Medical,” said Jim Corbett, AVITA Medical Chief Executive Officer.
  • “We had a high level of confidence in the FDA’s approval timeline of RECELL for the treatment of skin defects,” continued Mr. Corbett.
  • Currently, skin grafting is the standard of care for full-thickness skin defects, including post-trauma and post-surgical skin reconstruction.
  • The PMA supplement approval follows the original PMA approval of the RECELL System for the treatment of severe burns in September 2018.

Circana’s 2022 New Product Pacesetters Report Reveals that a Commitment to Innovation Drives CPG Sales

Retrieved on: 
Wednesday, June 7, 2023

In nonfood products, scent plays a crucial role in driving sales for many 2022 Pacesetters, including No.

Key Points: 
  • In nonfood products, scent plays a crucial role in driving sales for many 2022 Pacesetters, including No.
  • Plant-based food and beverages represent $411 million in 2022 Pacesetter sales, more than doubling the number of Pacesetter products and dollar sales in the previous three years.
  • “Big companies’ dollar share dipped from 50% in 2021 to 35% in 2022,” said Lisa Maas, principal and practice lead, Innovation, Circana.
  • In this year’s Pacesetters, brand extensions represent 54% of total food and beverage Pacesetters, while new brands represent 46%.”

Lux Revamp Delivers Aesthetic Laser Solutions in Neptune Beach, FL, Featuring the Astanza Duality Laser

Retrieved on: 
Wednesday, June 7, 2023

DALLAS, June 07, 2023 (GLOBE NEWSWIRE) -- Lux Revamp is a rising laser practice in Neptune Beach, Florida that specializes in removing unwanted tattoos and skin blemishes using the advanced Astanza Duality laser.

Key Points: 
  • DALLAS, June 07, 2023 (GLOBE NEWSWIRE) -- Lux Revamp is a rising laser practice in Neptune Beach, Florida that specializes in removing unwanted tattoos and skin blemishes using the advanced Astanza Duality laser.
  • Lux Revamp is officially opening its doors in June and provides a wide range of aesthetic services, including laser tattoo removal, vascular lesion removal, and pigmented lesion removal, and injectables.
  • Lux Revamp also uses the Zimmer Cryo cooling machine, a superior skin-numbing solution, for maximum patient comfort and skin alleviation.
  • “The Lux Revamp team is highly skilled and committed to the success of their clients,” said Bryce Fisher, Astanza Account Representative.

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

Retrieved on: 
Wednesday, June 7, 2023

Dr. Eschenbacher is an innovative business development executive with extensive experience in the healthcare industry.

Key Points: 
  • Dr. Eschenbacher is an innovative business development executive with extensive experience in the healthcare industry.
  • Focused on addressing access, adherence, and affordability across the continuum of healthcare, Dr. Eschenbacher works to ensure equity .
  • She addresses impactful issues by engaging with Boards of Pharmacy, professional organizations, and the U.S. Congress.
  • Dr. Eschenbacher also held a number of positions including Medication Safety Officer at Duke University Health System.

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

Retrieved on: 
Wednesday, June 7, 2023

PROVO, Utah, June 07, 2023 (GLOBE NEWSWIRE) -- Today, Nu Skin is hosting its 20th annual Force for Good Day to support its global humanitarian efforts.

Key Points: 
  • PROVO, Utah, June 07, 2023 (GLOBE NEWSWIRE) -- Today, Nu Skin is hosting its 20th annual Force for Good Day to support its global humanitarian efforts.
  • To celebrate the company’s founding and to give back to local communities, each Nu Skin region sets aside a day to participate in service projects as part of the company mission to be a global force for good.
  • At the Nu Skin global headquarters in Utah, this year's Force for Good Day is focused on extending kindness and support to children battling illnesses in hospitals or undergoing surgery.
  • More than 900 Nu Skin employees and their families will participate in a day of service to benefit 1,000 hospitalized children around the world.